| Literature DB >> 24876857 |
In-Jeong Cho1, Sung-Yeol Jang1, Hyuk-Jae Chang2, Sanghoon Shin1, Chi Young Shim2, Geu-Ru Hong1, Namsik Chung1.
Abstract
BACKGROUND AND OBJECTIVES: Screening strategies for aortic aneurysm (AA) according to risk factors and ethnicity are controversial. This study explored the prevalence of AA and determined whether screening is necessary in a population of multiple risk factors. SUBJECTS AND METHODS: From June, 2012 to April, 2013, 542 consecutive elderly (≥65 years) male hypertensive patients without a history of AA were prospectively enrolled. After excluding 15 patients (2.8%) with aortic valve surgery, 30 patients (5.5%) with suboptimal computed tomography (CT) images, the remaining 496 patients (age 73±5 years) comprised the study population. Maximal diameters of the thoracic and abdominal aorta were measured using non-contrast CT.Entities:
Keywords: Aneurysm; Aorta; Computed tomography; Prevalence
Year: 2014 PMID: 24876857 PMCID: PMC4037638 DOI: 10.4070/kcj.2014.44.3.162
Source DB: PubMed Journal: Korean Circ J ISSN: 1738-5520 Impact factor: 3.243
Fig. 1Measurement of aortic diameter in the axial plane. Ascending and descending thoracic aorta (A) and abdominal aorta (B). ATA: ascending thoracic aorta, DTA: descending thoracic aorta, AA: abdominal aorta.
Fig. 2Reconstructed images of aorta using non-contrast computed tomography. Reconstructed sagittal (A) and coronal (B) images of aorta.
Clinical characteristics of the study population
BSA: body surface area, AVR: aortic valve replacement, ACEi: angiotensin converting enzyme inhibitor, ARB: aldosteron receptor blocker, LDL-C: low density lipoprotein-cholesterol, HDL-C: high density lipoprotein-cholesterol
Fig. 3Histogram of maximal thoracic (A) and abdominal aorta (B). Red lines indicate maximal thoracic aorta of 40 mm and maximal abdominal aorta of 30 mm. TAMAX: maximal thoracic aorta, AAMAX: maximal abdominal aorta.
Fig. 4Prevalence of thoracic aortic aneurysm in patients with and without abdominal aortic aneurysm. TAA (-), patients without thoracic aortic aneurysm; TAA (+), patients with thoracic aortic aneurysm; AAA (+), patients with abdominal aortic aneurysm; AAA (-), patients without abdominal aortic aneurysm.
Fig. 5Prevalence of thoracic aortic aneurysm (A) and abdominal aortic aneurysm (B) according to history of smoking. Smoking (+), current or past smoker; Smoking (-), never smoked.
Logistic regression analysis of variables as determinants of thoracic aortic aneurysm and abdominal aortic aneurysm
CI: confidential interval, TAA: thoracic aortic aneurysm, AVR: aortic valve replacement, BSA: body surface area, BP: blood pressure, HDL-C: high density lipoprotein-cholesterol, LDL-C: low density lipoprotein-cholesterol, AAA: abdominal aortic aneurysm, ACEi: Angiotensin converting enzyme inhibitor, ARB: aldosteron receptor blocker, CCB: calcium channel blocker